Phase III Randomized Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]
Phase of Trial: Phase III
Latest Information Update: 26 Sep 2018
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Diagnostic use; Registrational
- Acronyms PSMA-SRT
- 17 Sep 2018 Status changed from not yet recruiting to recruiting.
- 17 Jul 2018 Planned primary completion date changed from 30 Jul 2023 to 1 Sep 2023.
- 17 Jul 2018 Planned initiation date changed from 30 Jul 2018 to 1 Sep 2018.